Earlier this year, the Food and Drug Administration approved the first treatment for peanut allergies. The drug, called Palforzia, doesn’t cure peanut allergies, but it does build resistance against them. 올해 초 식품의약국(FDA)은 땅콩 알레르기에 대한 최초의 치료법을 승인했습니다. 팔포지아(Palforzia)라는 약은 땅콩 알레르기를 치료하지는 않지만 땅콩 알레르기에 대한 저항력을 키워줍니다.

posted in: Pediatric News | 0

Earlier this year, the Food and Drug Administration approved the first treatment for peanut allergies. The drug, called Palforzia, doesn’t cure peanut allergies, but it does build resistance against them. 올해 초 식품의약국(FDA)은 땅콩 알레르기에 대한 최초의 치료법을 승인했습니다. 팔포지아(Palforzia)라는 약은 땅콩 알레르기를 치료하지는 않지만 땅콩 알레르기에 대한 저항력을 키워줍니다.

Tara Santora

Tue, November 3, 2020, 1:54 PM EST

Earlier this year, the Food and Drug Administration approved the first treatment for peanut allergies. The drug, called Palforzia, doesn’t cure peanut allergies, but it does build resistance against them. Many think this will be a game-changer for millions of families. But it’s not alone. From peanut patches to liquid drops, researchers have been hard at work looking for peanut allergy cures since 2017, when the FDA approved the health claim that early introduction of peanuts to infants helps prevent peanut allergies. The solutions are rounding the corner and it looks like 2021 could promise to be the year that peanut allergies became a thing to defeat, not live with.

소스: Yahoo News 3/2020